Longitudinal Changes in Natriuretic Peptides and Reverse Cardiac Remodeling in Patients with Heart Failure Treated with Sacubitril/Valsartan Across the Left Ventricular Ejection Traction Spectrum.


Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
30 Nov 2023
Historique:
medline: 1 12 2023
pubmed: 16 11 2023
entrez: 15 11 2023
Statut: ppublish

Résumé

Sacubitril/valsartan improves outcomes in patients with heart failure (HF) with reduced ejection fraction. However, the relationship between longitudinal changes in natriuretic peptides and echocardiographic parameters in patients with HF treated with sacubitril/valsartan across the left ventricular ejection fraction (LVEF) range is not fully understood.In patients with HF treated with sacubitril/valsartan, comprehensive data on natriuretic peptides, including atrial natriuretic peptide (ANP), N-terminal pro-brain-type natriuretic peptide (NT-proBNP), BNP, and echocardiography, were measured after 6 months of treatment. We assessed the change in natriuretic peptides and echocardiographic parameters in LVEF classification subgroups.Among 49 patients, the median ANP concentration increased from 55 pg/mL at baseline to 78 pg/mL (P < 0.001). The NT-proBNP concentration decreased from 250 pg/mL to 146 pg/mL (P < 0.001). No significant change was observed in the BNP concentration (P = 0.640). The trajectories of each natriuretic peptide in patients with LVEF > 40% (n = 22) were similar to those in individuals with LVEF ≤ 40% (n = 27). Regardless of LVEF classification, echocardiography at 6 months showed a significant improvement in LVEF, left ventricular end-diastolic volume, and the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/e'). The reduction in natriuretic peptide concentration was related to LV reverse remodeling and decreased left and right atrial pressures assessed by E/e' and inferior vena cava diameter.Sacubitril/valsartan induced an increase in ANP, a reduction in NT-proBNP, and no change in plasma BNP, regardless of LVEF. It caused LV reverse remodeling, and the natriuretic peptide concentration changes were associated with structural and functional echocardiographic parameters.

Identifiants

pubmed: 37967975
doi: 10.1536/ihj.23-407
doi:

Substances chimiques

sacubitril 17ERJ0MKGI
Tetrazoles 0
Valsartan 80M03YXJ7I

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1071-1078

Auteurs

Masayoshi Yamamoto (M)

Department of Cardiology, Faculty of Medicine, University of Tsukuba.

Tomoko Ishizu (T)

Department of Cardiology, Faculty of Medicine, University of Tsukuba.

Kimi Sato (K)

Department of Cardiology, Faculty of Medicine, University of Tsukuba.

Kentaro Minami (K)

Department of Cardiology, Graduate School of Comprehensive Human Sciences, University of Tsukuba.

Taikan Terauchi (T)

Department of Cardiology, Graduate School of Comprehensive Human Sciences, University of Tsukuba.

Tomofumi Nakatsukasa (T)

Department of Cardiology, Faculty of Medicine, University of Tsukuba.

Naoto Kawamatsu (N)

Department of Cardiology, Faculty of Medicine, University of Tsukuba.

Tomoko Machino-Ohtsuka (T)

Department of Cardiology, Faculty of Medicine, University of Tsukuba.

Masaki Ieda (M)

Department of Cardiology, Faculty of Medicine, University of Tsukuba.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH